top of page

Media Coverage

March 15, 2023


Researchers from Rowan and Durin Technologies announce highly accurate blood test for Alzheimer’s Disease

A team of researchers from Rowan-Virtua School of Osteopathic Medicine (Rowan-Virtua SOM) and Durin Technologies, Inc., have announced the results of a newly-designed blood test that can detect the presence of Alzheimer’s disease-related pathology up to 10 years before symptoms arise with a nearly 97 percent accuracy rate. 

March 14, 2023


Autoantibody-Based Alzheimer's Test by Durin Technologies Moving Toward Potential Commercialization

Diagnostics firm Durin Technologies is moving toward commercialization of its blood-based test for the early detection of Alzheimer's disease.

December 23, 2019

South Jersey health care startup raises $3.5 million

A South Jersey life sciences company working on a test that can detect Alzheimer's at an early-stage has received a $3.5 million investment.

bottom of page